Document is current
Any future updates will be listed below
-
Authors
Kalinin, Alexandr A. https://orcid.org/0000-0003-4563-3226
Arevalo, John https://orcid.org/0000-0002-1138-5036
Serrano, Erik
Vulliard, Loan https://orcid.org/0000-0002-2260-4935
Tsang, Hillary
Bornholdt, Michael
Muñoz, Alán F.
Sivagurunathan, Suganya https://orcid.org/0000-0002-9778-5400
Rajwa, Bartek
Carpenter, Anne E. https://orcid.org/0000-0003-1555-8261
Way, Gregory P. https://orcid.org/0000-0002-0503-9348
Singh, Shantanu https://orcid.org/0000-0003-3150-3025
-
Funding
Funding for this research was provided by:
Human Frontier Science Program (RGY0081/2019)
This work was supported by Calico Life Sciences, LLC.
U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (T15LM009451)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM122547)
This research was, in part, funded by the United States Government, ARPA-H
- License Information
-
More Information
Article History
Received: 5 April 2024
Accepted: 16 May 2025
First Online: 4 June 2025
Competing interests
: The Authors declare the following competing interests: Sh.S. and A.E.C. serve as scientific advisors for companies that use image-based profiling and Cell Painting (A.E.C.: Recursion, SyzOnc, Quiver Bioscience, Sh.S.: Waypoint Bio, Dewpoint Therapeutics, Deepcell) and receive honoraria for occasional scientific visits to pharmaceutical and biotechnology companies. All other authors declare no competing interests.
